Novo Nordisk (NVO) Leads Alzheimer’s Prevention Race, But Eli Lilly (LLY) Could Win the Market
Alzheimer's disease is common, fatal, and scary. It robs you of your mind. More than 7 million Americans suffer from this disease, with another 500,000 being diagnosed every year. Mostly, this disease affects the senior set, with one notable exception: about 4% of people with European heritage have a genetic flaw that plays out in […]
October 6, 2025
|David Lashmet